|
Volumn 256, Issue 1, 2009, Pages 13-27
|
Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies
|
Author keywords
Bethlem myopathy; Central Core Disease (CCD); Joint hypermobility; Multiminicore Disease (MmD); Myopathy; Ullrich congenital muscular dystrophy
|
Indexed keywords
ACTIVIN A;
ALPHA9 INTEGRIN;
BETA SARCOGLYCAN;
COLLAGEN TYPE 1;
COLLAGEN TYPE 3;
COLLAGEN TYPE 5;
COLLAGEN TYPE 6;
CREATINE KINASE;
FIBRILLIN;
INTEGRIN;
LAMININ RECEPTOR;
RYANODINE RECEPTOR;
SELENOPROTEIN;
TENASCIN;
UNCLASSIFIED DRUG;
BETHLEM MYOPATHY;
CENTRAL CORE DISEASE;
CLINICAL FEATURE;
CONNECTIVE TISSUE DISEASE;
CREATINE KINASE BLOOD LEVEL;
DIFFERENTIAL DIAGNOSIS;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
EHLERS DANLOS SYNDROME;
GENE MUTATION;
GENETIC DISORDER;
HUMAN;
JOINT CONTRACTURE;
JOINT HYPERMOBILITY;
KYPHOSCOLIOSIS;
LIMB GIRDLE MUSCULAR DYSTROPHY;
MARFAN SYNDROME;
MULTIMINICORE DISEASE;
MUSCLE BIOPSY;
MUSCULAR DYSTROPHY;
MYOPATHY;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
REVIEW;
SCORING SYSTEM;
ULLRICH CONGENITAL MUSCULAR DYSTROPHY;
ANIMALS;
CONNECTIVE TISSUE;
DIAGNOSIS, DIFFERENTIAL;
EHLERS-DANLOS SYNDROME;
HUMANS;
JOINT INSTABILITY;
MARFAN SYNDROME;
MUSCULAR DYSTROPHIES;
|
EID: 62149092195
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-0105-1 Document Type: Review |
Times cited : (41)
|
References (69)
|